nNOS activity and NO production goes on inside the neuron, Dr. Iadecola points out. "That means there's some kind of biochemical chain connecting external tPA to these internal mechanisms," he says. "Identifying the key players in that pathway will be a key part of our research going forward."
The new discoveries will have exciting implications for brain research, he says.
"More and more, we are realizing that alterations in the availability of blood to brain cells is crucial to stroke and post-stroke recovery, and in the debilitating loss of neuronal function that underlies Alzheimer's disease and other dementias," Dr. Iadecola says.
"It is possible that drugs or other interventions that manipulate the brain's natural supply of tPA could help preserve neurological function after stroke or Alzheimer's, or even help reverse some of the damage," he says. "Those types of treatments are still a long way off, but our new understanding how tPA works to keep neurons healthy and active is a crucial first step in that research."
'/>"/>
Page: 1 2 3 Related biology news :1.
$13 million federal grant for research into vascular disease awarded to Weill Cornell2.
2 federal public health grants awarded to Weill Cornell Medical College3.
Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports4.
Cornell patents a pink lily look-alike that blooms all summer long5.
Cornell researchers prove how plants transport sugars6.
Cornell researcher seeks clues to how tuberculosis infects cells7.
Wiggle room: Cornell researcher borrows idea from sperm to provide energy for nanoscale robots8.
First symposium of UN University-Cornell Africa Series to be held at UN9.
Cornell will host the Northeast Biofuel Summit, Nov. 11-1310.
CU-Boulder team discovers first ancient manioc fields in Americas11.
deCODE discovers cause of major subtype of glaucoma